Fidelity Investments’s Perspective Therapeutics CATX Stock Holding History
Bought
Maintained
Sold
Other funds holding CATX
Fidelity Investments's CATX Position: Q3 2026 in Review
Fidelity Investments reduced its Perspective Therapeutics (CATX) stake by 18% in Q3 2026, selling an estimated $180K and leaving 268,001 shares worth $737K. The position accounts for ﹤0.01% of the portfolio, ranked #3147.
Fidelity Investments first reported a position in CATX in Q3 2019 and has held it in 16 quarters since. The position peaked at $73.5M in Q3 2024. 120 funds tracked by Wall St. Rank hold CATX as of Q3 2026.
- Fidelity Investments held 268,001 shares of Perspective Therapeutics worth $737K as of Q3 2026.
- Fidelity Investments sold 59,252 Perspective Therapeutics shares in Q3 2026, an estimated $180K.
- Perspective Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #3147 holding.
- Fidelity Investments first reported a position in Perspective Therapeutics in Q3 2019 and has held it in 16 quarters since.
- Fidelity Investments's Perspective Therapeutics position peaked at $73.5M in Q3 2024.
- 120 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q3 2026.
Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.